LeonaBio, Inc. (LONA) — Institutional Holders & Catalysts | BiotechEdge

BiotechEdgeBeta

Catalysts Convergence Compare Insiders Runway Squeeze Signals Research

Sign In Start Free Trial

← Back to home

LeonaBio, Inc.

LONA

Held by 2 specialist biotech funds

Fund Holdings

B

BiotechEdge

Catalysts Convergence Insiders Cash Runway Research Pricing

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback Terms Privacy Disclaimer

Commodore CapitalNew

Perceptive AdvisorsNew

Catalysts

No catalysts tracked.

Activist Filings

SC 13D/APerceptive Advisors20.0%Jan 16, 2026

SC 13D/APerceptive Advisors20.0%Dec 23, 2025

SC 13D/APerceptive Advisors13.7%Dec 22, 2025

Position Details

Commodore CapitalNEWFeb 17, 2026

Shares: 464,398Value: $3.5M

Perceptive AdvisorsNEWFeb 17, 2026

Shares: 1,859,322Value: $14.1M

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

AMLX2 funds ANRO2 funds COGT2 funds CTNM2 funds CNTA2 funds ORKA2 funds PTGX2 funds APGE2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: